13F filer · CIK 2018299
Boxer Capital Management, LLC
San Diego, CA · filing since Q4 2024 · last filing Aug 14, 2026
Reported value
$1.3B
+$566.1M vs prior
Positions
63
New / sold out
12 / 3
Added / reduced
17 / 1
Turnover
2.8%
buys $339.9M · sells $29.4M
Top-10 weight
65.1%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | ABIVAX SA | +405,000 | +202.5% | +$54.0M |
| New | Q32 BIO INC | +3,149,310 | – | +$40.1M |
| Added | UNIQURE NV | +841,300 | +127.1% | +$38.8M |
| Added | REPLIMUNE GROUP INC | +2,808,000 | +239.0% | +$31.1M |
| Added | CELCUITY INC | +191,530 | +85.1% | +$20.0M |
| Added | CAPRICOR THERAPEUTICS INC | +805,156 | +136.5% | +$19.4M |
| Added | DEFINIUM THERAPEUTICS INC | +400,000 | +66.8% | +$18.8M |
| Added | KYMERA THERAPEUTICS INC | +100,000 | +30.4% | +$11.5M |
| Added | PRECIGEN INC | +1,650,000 | +47.1% | +$9.4M |
| Added | OCULAR THERAPEUTIX INC | +950,000 | +271.4% | +$9.3M |
19 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | TERNS PHARMACEUTICALS INC | -375,000 | -100.0% | $-19.8M |
| Sold out | SOLENO THERAPEUTICS INC | -200,000 | -100.0% | $-6.7M |
| Reduced | ALLOGENE THERAPEUTICS INC | -1,225,000 | -45.0% | $-2.5M |
| Sold out | KALVISTA PHARMACEUTICALS INC | -20,400 | -100.0% | $-410.7K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | TANGO THERAPEUTICS INCCOM | 10,876,219 | $340.0M | 25.61% |
| 2 | REVOLUTION MEDICINES INCCOM | 500,000 | $93.6M | 7.05% |
| 3 | ABIVAX SASPONSORED ADS | 605,000 | $80.6M | 6.07% |
| 4 | UNIQURE NVSHS | 1,503,300 | $69.2M | 5.21% |
| 5 | KODIAK SCIENCES INCCOM | 1,477,600 | $57.6M | 4.34% |
| 6 | KYMERA THERAPEUTICS INCCOM | 429,100 | $49.2M | 3.71% |
| 7 | DEFINIUM THERAPEUTICS INCCOM SHS | 998,500 | $47.0M | 3.54% |
| 8 | REPLIMUNE GROUP INCCOM | 3,983,000 | $44.1M | 3.32% |
| 9 | CELCUITY INCCOM | 416,530 | $43.6M | 3.28% |
| 10 | Q32 BIO INCCOM | 3,149,310 | $40.1M | 3.02% |
53 more rows. Subscribe for $29/month to see every row, download the data and use the API.